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Abstract
Background The post-discharge Medicines-Use-Review (dMUR) is a commissioned service in England and Wales whereby 
community pharmacists facilitate patients’ understanding of their medicines and resolve any medicine-related problems. This 
service is poorly utilised. Objective To explore the impact of raising hospital patients’ awareness of dMURs on their uptake. 
Setting Hospital in South East England. Method Patients on medical wards with at least one change (medicine, or dose regi-
men) to their admission medicines were provided with standardized written and verbal information about the service. Par-
ticipants were responsible for their own medicines and anticipated that they would be discharged home. Structured telephone 
interviews conducted 4 weeks after discharge explored any medicine-related issues experienced, and reasons for engaging, 
or not, with the dMUR service. Responses to closed questions were analysed using descriptive statistics. Responses to open 
questions were analysed thematically. Ethics approval was obtained. Main outcome measure Proportion of patients who 
received a dMUR and their motivations or barriers to accessing the service. Results Hundred patients were recruited and 84 
interviewed. Their mean (SD) age was 73 (11) years. They were taking a median (range) of 9 (2–19) medicines. 67% (56/84) 
remembered receiving information about dMURs. Nine (11%) had attempted to make an appointment although four had not 
received the service because the pharmacist was unavailable. Most (88%) were not planning to access the service. The most 
common reason given was poor morbidity or mobility (13/31, 42%). Conclusion The use of written and verbal information 
to encourage patients to use the dMUR service had minimal impact.
Keywords Community pharmacists · England and Wales · Hospital discharge · Hospital pharmacy service · Medication 
counselling · Medicine use reviews · Pharmacy services
Impacts on practice
• Signposting patients to access the dMUR service by 
providing information to enhance their awareness of the 
service is minimally effective.
• Poor mobility and morbidity are the most common reason 
given for not accessing the dMUR-service.
• The personal relationship between patient and their com-
munity pharmacist is a key influencing factor on patient’s 
willingness to have dMUR.
• Routinely available domiciliary dMURs should be com-
missioned to improve the accessibility of the service to 
all patients.
Introduction
Patients with chronic illnesses receive care in different set-
tings and it is estimated that 30–70% of patients experience 
a medicine error when moving between care settings [1, 2]. 
At hospital admission or discharge, the potential for harm 
resulting from unintended medicine discrepancies has been 
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reported to range from 11 to 59% [3]. Medicines recon-
ciliation, the process of comparing a patients’ prescribed 
medicines on admission to hospital with the medicines that 
were being taken at home, has been shown to support patient 
safety [4] and has been identified as a priority for action 
by the World Health Organisation (WHO) for adoption 
globally [5]. Guidance to hospitals in England and Wales 
recommends that to improve transitions of care, patients 
should have their medicines reconciled, ideally within 24 h 
of admission, to ensure pre-admission medicines are cor-
rectly prescribed [6].
Elderly medical patients are often discharged from hos-
pital with planned changes to their medicines, but rarely 
receive adequate information on new medicines or why 
medicines have been stopped [7]. Discharge counselling has 
been recommended to support adherence post-discharge [8]; 
however, providing medicines information at discharge is 
not always ideal as patients have other concerns, illustrating 
the importance of reinforcing medicines information after 
discharge [1, 9].
The Medicines-Use-Review (MUR) is a contracted ser-
vice in England and Wales in which an accredited pharma-
cist provides a structured adherence-based consultation in 
the community pharmacy. A rapid review of MURs in 2016 
concluded that there was no evidence to support the clinical 
or cost effectiveness of the service [10], even though it was 
demonstrated to improve patients’ knowledge about their 
medicines and was associated with a high level of patient 
satisfaction. Considerable variability in the delivery of the 
service has been reported with independent pharmacies 
less likely to offer the service [11]. Pharmacists have also 
reported increased workload and work based stress asso-
ciated with providing MURs in addition to their essential 
contracted services [12]. Early evaluations of this service 
recommended that strategies to target those patients who 
would derive greatest benefit should be developed [13].
Review of medicines by a pharmacist after transitions of 
care may increase the appropriateness of medicine use [14]. 
Since 2011 patients whose pre-admission medicines have 
changed or who have had new medicines started in hospital, 
can receive a targeted MUR, known as a Discharge Medi-
cines-Use-Review (dMUR), with their community pharma-
cist. This service should be carried out within 4 weeks of 
discharge. However, the uptake of the dMUR service has 
been reported to be low in a number of studies [15–17]. Bar-
riers to recruiting patients to post-discharge MURs include 
patients being housebound, requiring support with their 
medicines and not expecting to benefit from the review.
Aim of the study
To determine whether a hospital pharmacy service develop-
ment to raise awareness of the dMUR service would lead to 
its uptake in the community, and to explore patients’ motiva-
tions for engaging with this service.
Ethics approval
The study was approved by the National Research Ethics 
Committee (15/SC/0111) and the NHS Trust Research Gov-
ernance Department (2014/PHARM/01). All written infor-
mation met the Trust information governance requirements.
Method
Intervention
The pharmacy service introduced an initiative as part of 
standard care to raise patients’ awareness of the dMUR ser-
vice. The intervention had two stages. The first stage was 
carried out by the clinical pharmacy team (pharmacists and 
clinical pharmacy technicians) during medicines reconcili-
ation and comprised a written information leaflet accompa-
nied by standardised verbal advice to encourage the patient 
to access the dMUR service. For the second stage, a written 
information leaflet and a reminder label were added to the 
discharge medicines bag. The information leaflet and label 
were developed from a nationally available template [18]. 
They were drafted, checked using the Flesch Reading Ease 
scale to ensure the score met Plain English standards then 
tested for content understanding by non-pharmacist readers. 
They were then submitted to the Trust Patient Information 
Committee where they were appraised and approved.
Setting, participants and study design
This study was conducted on general medicine wards, the 
admissions ward and coronary care unit at one hospital 
in South-East England. One of the researchers, who was 
employed as a pharmacist at the hospital, recruited patients 
from those who had undergone medicines reconciliation 
using a convenience sampling approach. Patients were 
recruited up to the target number of 100, between May and 
July 2015. Patients who met the inclusion criteria were 
informed verbally about the purpose of the study, provided 
with a written participant information leaflet and given at 
least 24 h to decide whether to take part. Having given their 
written consent to participate and to take part in a structured 
telephone interview 4 weeks after discharge, they were then 
asked to complete a questionnaire.
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Inclusion criteria
Patients recruited were: taking medication on a regular basis 
for long term conditions with at least one change in either a 
medicine or a dose regimen during the hospital admission; 
expected to be discharged home and responsible for their 
own medicines; had received medicines reconciliation.
Patients with cognitive impairment, unable to consent, 
undergoing chemotherapy treatment, receiving palliative/
end of life care, < 18 years of age, with no changes in pre-
admission medication, or who were to be discharged to a 
care home or rehabilitation hospital were excluded.
Questionnaire
The inpatient questionnaire obtained participants’ demo-
graphics and explored their concerns with medicines and 
any prior experience of the MUR service. These factors have 
been identified in the literature as potentially influencing a 
patient’s motivation for accessing an MUR [19, 20]. The 
questionnaire was developed from a previous study inves-
tigating the awareness of the general public of community 
pharmacy services and included both open and closed ques-
tions [21].
Telephone interview
All participants were contacted by telephone approxi-
mately 4 weeks after their discharge for a 10-min structured 
interview developed by the research team. The purpose of 
the interview was to identify whether the participant had 
experienced any issues with their medicines on returning 
home and to establish whether they had accessed a dMUR. 
Their reasons for engaging with the service or otherwise 
were explored. The interview was audio recorded. Prior to 
contacting the participant, the participant’s medical his-
tory and regular medicines were obtained from their elec-
tronic discharge letter to provide broader context [medical 
condition(s) and number of medicines] without burdening 
the participant by asking them to provide this information.
Analysis
The audio-record of the interviews was used for verifica-
tion of all questions. Responses to closed questions were 
coded and entered onto a single Excel spread sheet. Coded 
data from the Excel spreadsheet were transferred to SPSS 
(Version 22) and analysed. Descriptive statistics were used 
to summarise the variables. Responses to open questions 
were transcribed verbatim and analysed by two researchers 
independently to promote trustworthiness [22]. Transcripts 
were coded and emerging themes were identified. Any dif-
ferences between researchers were discussed and a consen-
sus reached. A flow chart which summarises the recruitment 
and data collection process is provided in Fig. 1.
Results
100 patients were recruited into the study over 3 months. 
The response rate to the follow-up interview was 84%. 
Most patients were female (61%) with a mean (SD) age of 
73 (11) years. The majority (89%) of patients experienced 
polypharmacy (≥ 5 medicines) [23]. Table 1 summarises 
participant demographics and characteristics. The majority 
of the participants had multi-morbidity, of which the three 
most common conditions recorded for participants were 
hypertension (58%), atrial fibrillation/cardiac dysrhyth-
mias (33%) and acute coronary syndrome (ACS) (22%). 
The mean (SD) duration between discharge and interview 
was 28 days (± 4.3 days).
Access to a dMUR post‑discharge
Nine (11%) patients had attempted to access the dMUR 
service 4 weeks after discharge. Of these, three were not 
given an appointment and one did not receive a review due 
to the pharmacist being on holiday when they attended. 
This patient on returning home had concerns about the 
side effects of her regular medicines. She had not previ-
ously had an MUR.
None of the remaining five patients expressed any prob-
lems with taking their medicines nor had concerns about 
their medicines either in hospital or after discharge. All 
had had a previous MUR either in the community phar-
macy or at their own home (one patient) and viewed their 
pharmacist positively. All stated the dMUR session had 
been helpful and that they would recommend the service 
to their family and friends.
The patients who had made an appointment for a dMUR 
reported that they expected the pharmacist to go through 
their medicines with them (50%, 3/6). They wanted to find 
out the indication for each medicine and how to take them 
(33%, 2/6). Three obtained their repeat supplies them-
selves; the others relied on a friend or delivery service for 
their repeat medicine supplies. Five out of six had had at 
least one prior admission to hospital within the previous 
12 months.
Eighty nine percent (75/84) of participants had chosen not 
to access the dMUR service and most (66/75, 88%) were not 
planning to do so in the future. One participant was unsure.
Thirty-one patients gave a reason for not accessing a 
dMUR with 11 (35%) citing difficulties in getting to the 
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Fig. 1  Recruitment and data 
collection process Medicines reconciliaon conducted by clinical pharmacy team – provided paent with standardised 
verbal advice and wrien informaon leaflet on dMUR
Researcher assessed on the ward if paent met 
inclusion criteria
Researcher informed paent of the study purpose and
provided wrien parcipant informaon and consent 
form
If paent consented to parcipate - parcipant 
completed inpaent quesonnaire
Responses to closed quesons were coded and 
entered onto an Excel spreadsheet
Responses to open quesons were transcribed 
verbam and entered onto Excel spreadsheet
Prior to contacng the parcipant, parcipant’s 
medical history and regular medicines were obtained 
from their electronic discharge leer
Paent contacted for a 10-minute structured 
telephone interview
Interview was audio-recorded
4 weeks aer 
hospital discharge
Aer at least 24 hours
Table 1  Summary of patient characteristics
*Five missing responses
Participant characteristics Valid responses
Gender Male Female
% 39 61
Age (years) Mean ± SD
73.3 ± 10.8
No. of regular medicines Median Range
9 2–19
Education level* Up to secondary school College/further education University degree Higher degree
% (n) 67.4 (64) 21.1 (20) 10.5 (10) 1.1 (1)
Ethnicity White Mixed/multiple ethnic groups Asian Black Other
% (n) 98 (98) 2 (2) 0 0 0
No. of hospital admissions 
within the last 12 months
First admission Twice 3 times 4 times 6 times
% (n) 62 (62) 22 (22) 9 (9) 4 (4) 3 (3)
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pharmacy. Two patients were too unwell to attend. Some 
patients (6/31, 19%), who viewed their GP as their pri-
mary source of information, did not perceive the need to 
engage with the service because their medicines would be 
reviewed by the GP or specialist.
Patient-reported motivational factors given for con-
sidering a dMUR in the future included being invited to 
do so by the pharmacist (19%, 6/31), having questions or 
concerns about medicines (16%, 5/31), improved mobility 
or health conditions (10%, 3/31), or if there were further 
changes to their medicines (6%, 2/31). Comments from 
participants who had or had not engaged with the dMUR 
service are provided in Table 2.
Usefulness of information on the dMUR provided 
by the hospital
Two thirds (67%, 56/84) of patients recalled receiving infor-
mation about the dMUR. Twenty-two (26%) were not sure 
and 6 (7%) patients did not remember. Almost all of those 
who remembered (95%, 53/56) felt the information provided 
was useful, including all nine patients who had already 
attended or attempted to make an appointment.
Patient factors that might benefit from a dMUR 
and their impact on dMUR uptake
Twenty-three patients (23%) expressed worries about their 
medicines before discharge home. Common worries were 
side-effects, potential drug interactions and not under-
standing their medicines. However, despite this only four 
of this group either accessed a dMUR or made an appoint-
ment for a dMUR. Reasons for not accessing a dMUR by 
this group of patients were that they would be seen or 
had been seen by their doctor/specialist (35%, 8/23), their 
pharmacist reviewed their medicines regularly (9%, 2/23), 
they would seek help if needed (9%, 2/23), that they talked 
to their pharmacist over the phone (4%, 1/23), that they 
were housebound (4%, 1/23) or their wife sorted out all 
their medicines for them (4%, 1/23).
Almost one-third of patients interviewed in hospital 
(32%, 32/100) had problems getting their medicines out 
of the packets. Frequently reported problems were the foil 
blister packaging, small tablets and limited manual dexter-
ity due to conditions such as arthritis. Only one of these 
patients planned to access a dMUR. Similarly, although 
13% of patients (13/100) reported having had swallowing 
problems with their medicines, attributed to large tablets, 
powder/non-coated tablets and tablets with an odd shape 
Table 2  Thematic analysis of patients’ views on dMUR service
Theme Quotation Attribution
Facilitators
Need for information I’ve got all these new tablets started, I want to get 
them sorted and know what they are for.
P70, female aged 90 years, 8 regular medicines. 
Planned to attend a dMUR
Invitation to attend They actually take you into the little room and talk 
you through your tablets every once in a while. I 
will wait for them to take me in
P62, female aged 85 years, 11 regular medicines.
Relationship with Pharmacist She went through my tablets and she’s satisfied with 
them and I’m satisfied as well
P52, male aged 85 years, 8 regular medicines, dMUR
Barriers
Access to pharmacy Can’t walk far, housebound. Husband deals with 
prescriptions and the tablets are delivered from the 
chemist
P26, female aged 55 years, 12 regular medicines
Hierarchy of roles Dr will explain all the tablets when I go see him at 
the next appointment, don’t feel the need to go see 
the pharmacist
P69, female aged 86 years, 9 regular medicines
Satisfaction with dMUR service Very detailed advice on side effects. Very helpful 
and supportive. It’s very good to know all about the 
tablets, what they are for, side effects, how to take 
them and what to look out for, she said if I have any 
problems with the tablets, come back and we could 
go to the Dr together and may be able to give you 
something else. She’s very thorough. The session is 
very structured
P100, female aged 67 years, 8 regular medicines. 
dMUR
She went through them and got them all sorted. 
Explained that I need to stop taking clopidogrel 
after 28 days. Very helpful.
P 56, male aged 82 years, 10 regular medicines. dMUR
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being difficult to swallow only three were planning to dis-
cuss these issues with their pharmacist.
Previous access to medicine support 
in the community
Approximately one third of recruited patients (32%, 32/100) 
stated that they had received medicines support such as 
advice on side-effects or over-the-counter products from the 
community pharmacist. Forty-seven (47%) of patients were 
aware of the MUR service prior to their admission to hospi-
tal while over half (55%) stated that they would like to have 
a discussion with the pharmacist about their medicines when 
they got home. Nine patients (9%) had had a discussion with 
their community pharmacist about their medicines after 
previous hospital discharges. Three of these had accessed a 
dMUR following the current admission.
Discussion
Key findings
This paper describes the impact of a service development 
by hospital pharmacy staff to encourage the uptake of the 
community pharmacy dMUR service. Verbal and written 
information about the dMUR service was provided during 
the hospital stay yet a third of participants either weren’t sure 
or definitely couldn’t remember receiving this information. 
This highlights the vulnerability of this group of patients and 
suggests that standard approaches for providing information 
are not effective. Those who did remember found it very 
informative. However, the leaflets and verbal encouragement 
were only minimally effective as a strategy to encourage 
uptake of dMURs.
Only 11% of patients contacted 4 weeks after discharge 
had attempted to book an appointment for a dMUR, although 
a further 10% were still considering accessing a dMUR or 
MUR. Those who had received a dMUR thought that the 
consultation had been beneficial. The difficulties many 
patients experience in visiting the community pharmacy in 
person either due to poor mobility and/or ill-health has been 
reported by others [24] and was identified as a key barrier to 
the provision of dMURs in this study.
Regarding the patient’s doctor rather than their pharma-
cist as the main source of medicine information was also 
given as a reason for not making an appointment to see the 
pharmacist. Although 23% of patients expressed concerns 
about their medicines, this generally did not persuade them 
to go for a dMUR. This contradicts the findings of earlier 
studies that have reported that patients who express some 
concerns with their medicines are more willing to use the 
MUR service [19] or to seek information [20]. Practical 
problems such as difficulty swallowing medicines or get-
ting medicines out of the containers also did not appear to 
be seen to be reasons to see a pharmacist, even though many 
such issues could be addressed through a dMUR.
The majority of patients who had accessed a dMUR did 
not have concerns or issues with their medicines, but appear 
to have been motivated to go because of the positive rela-
tionships that they described with their community pharma-
cists. The strength of the relationship between pharmacist 
and patient as a key factor in decisions about accessing a 
service has been reported previously [25]. Of concern is the 
finding that four patients attempted but failed to receive the 
service as the pharmacist was unavailable.
Strengths and limitations
The clinical pharmacy team was trained to provide standard-
ised information on dMUR to all patients. One researcher 
was involved in the study from patient recruitment to data 
analysis. Both strategies were intended to minimise bias. 
This study explored the reasons for the low uptake of the 
dMUR service from the patient perspective.
A relatively small convenience sample of 100 patients 
was recruited to the study and recruitment took place in one 
hospital, from which the population was mainly Caucasian. 
Patients were recruited if they stated that they were respon-
sible for their own medicines. However, this may not have 
reflected their situation on discharge home. The number 
of patients lost to follow-up was low and the response rate 
to the telephone interview was high (84%). The possibil-
ity that some patients might not have fully understood what 
was being asked could not be excluded, which could lead 
to potentially inaccurate responses. As the number of par-
ticipants attending a dMUR was low it is unlikely that the 
thematic analysis of the open questions within the interview 
reached data saturation.
Interpretation
dMURs were commissioned to improve safety by reducing 
the number of unintended medicine discrepancies on transi-
tion of care. However, many patients, and potentially those 
most vulnerable, cannot access the service because they are 
too unwell or housebound to travel to the pharmacy. The 
contractual specification for the dMUR service needs to be 
extended so that pharmacists can provide domiciliary care 
to those in need of medicine support. Domiciliary MURs 
have been shown to highlight medicines wastage and adher-
ence issues [26] for the housebound and are acceptable to 
patients [27].
Earlier studies have suggested that there is low public 
awareness of extended community pharmacy services such 
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as dMUR [17, 21] and that patients often do not recognise 
their own needs for medicine support [28]. More effective 
methods to inform the public about the added value that 
a consultation with a pharmacist can provide need to be 
developed. These could focus on encouraging patients to 
build relationships with their community pharmacist rather 
than focusing on the services that the pharmacy can offer. 
A potential facilitator proposed by our study participants 
was that they received an invitation for a dMUR from the 
pharmacist. This has been suggested as a means to increase 
uptake by others [29]. However, this would need to be facil-
itated by the routine sharing of discharge communication 
between the hospital and the community pharmacist.
Pharmacists welcome opportunities for clinical roles, 
however high workload pressures often limit the time avail-
able for such activities [30]. Providing domiciliary dMURs 
may not be feasible unless changes are made to free pharma-
cists from routine tasks associated with the supply of medi-
cines, thus allowing them to use their knowledge and skills 
to best effect. High workload impedes time and opportunity 
to develop relationships with people, which our data suggest 
was a key influencing factor when considering whether to 
access a dMUR.
Conclusion
The hospital pharmacy initiative to provide information and 
advice to patients to use the dMUR service had minimal 
impact in encouraging uptake. The main reasons patients 
gave for not accessing a dMUR were: their lack of perceived 
need for medicine support; their reliance on their doctors to 
review and make decisions about their medicines; or their 
reduced capability to access the pharmacy either because of 
their morbidity or restricted mobility. Some patients stated 
that they would be more likely to go for a dMUR if they 
received an invitation from their community pharmacist. 
Those patients who did request a dMUR and received one 
found it to be of value to them.
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